Abstract
Growing data suggest that lymphadenectomy is a critical component of the surgical management of urologic malignancies with both diagnostic and therapeutic benefit. The increased use of minimally invasive approaches for the management of urologic malignancies may be in conflict with the need for more extensive lymphadenectomy with these procedures. The purpose of this review is to summarize the current evidence for lymphadenectomy as a staging and/or therapeutic procedure for urologic oncology procedures, summarize the feasibility of lymphadenectomy for these disease processes using a minimally invasive approach, and make recommendations regarding management of these disease processes using minimally invasive approaches. A literature review using MESH terms to identify literature on lymphadenectomy in urologic oncology (including minimally invasive urologic oncology procedures) was performed. This literature was the summarized by disease process and by its relation to minimally invasive procedures. The literature demonstrates that lymphadenectomy can successfully duplicate that performed for open urologic oncology procedures. The application of minimally invasive approaches, however, requires advanced skills to be able to accomplish this.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.